BAM
LUNG icon

Bellevue Asset Management’s Pulmonx LUNG Stock Holding History

Bellevue Asset Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-64
Closed -$1K – 489
2022
Q3 		$1K Buy
+64
New +$1.18K ﹤0.01% 475
2022
Q1 		– Sell
-45
Closed -$1K – 555
2021
Q4 		$1K Sell
45
-3
-6% -$110 ﹤0.01% 547
2021
Q3 		$2K Hold
48
– – ﹤0.01% 527
2021
Q2 		$2K Buy
48
+8
+20% +$348 ﹤0.01% 530
2021
Q1 		$2K Sell
40
-1
-2% -$57 ﹤0.01% 580
2020
Q4 		$3K Buy
+41
New +$2.01K ﹤0.01% 527

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Bellevue Asset Management's LUNG Position: Q4 2022 in Review

Bellevue Asset Management sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 64 shares — an estimated $1K sold.

Bellevue Asset Management first reported a position in LUNG in Q4 2020 and held it in 6 quarters. The position peaked at $3K in Q4 2020. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

  • Bellevue Asset Management reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
  • Bellevue Asset Management sold 64 Pulmonx shares in Q4 2022, an estimated $1K.
  • Bellevue Asset Management first reported a position in Pulmonx in Q4 2020 and held it in 6 quarters.
  • Bellevue Asset Management's Pulmonx position peaked at $3K in Q4 2020.
  • 116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Bellevue Asset Management's 13F filing for Q4 2022, filed 23 Jan 2023.